Ireland
--:--IST
Enrolling by invitation Observational

Standard Follow-up Program (SFP) for Breast Cancer Patients

NCT06429995 · tracked via the Priya Life Science Netherlands tracker
Phase
Observational
Started
2008-01-01
Last updated
2024-05-28

Condition(s) studied

Breast Cancer

Investigational drug(s) / intervention(s)

Radiotherapy

Study summary

Motive:

In order to improve the treatment technique, a comprehensive follow-up program is needed to obtain all relevant patient, treatment and toxicity data from breast cancer patients.

Goal:to set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life.

A standard database of patiënts receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.

To set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life.

A standard database of patients receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria: * Patients with breast cancer Patients receiving a radiotherapy dose Exclusion Criteria: * Failure to comply with any of the inclusion criteria

Primary outcome measure(s)

  • Score of Acute toxicity — Before start of radiation therapy and during radiation therapy and at 2 weeks after last day of radiation therapy.
    Acute Toxicity is measured with Common Terminology Criteria for Adverse Events (CTCAE).
  • Score of Late toxicity — At one and two years after last day of radiation therapy.
    Late Toxicity is measured with Common Terminology Criteria for Adverse Events (CTCAE).

Trial sites (1)

FacilityCityRegionStatus
University Medical Center Groningen Groningen Netherlands
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06429995 on ClinicalTrials.gov ↗ ← All trials in the Netherlands